东方财富网 > 数据中心 > 研报大全 > 鹏博士 > 鹏博士-研报正文
  • 最新价 -
  • 涨跌 -
  • 涨跌幅 -
  • 换手 -
  • 总手 -
  • 金额 -

Costs were lower but so was the topline

www.eastmoney.com 2017年08月30日 00:00 James Wang,Peter Milliken

鹏博士(600804)

Current price not factoring in the significant slowdown

Dr. Peng continues to see pressure in its core broadband business withbroadband access revenue down 6% and its net adds slowing to ~100k in2Q17, the lowest rate in the past 4-5 years. Meanwhile, gross margin andARPU continue to decline and the business had to cut its opex by 10% in orderto deliver a more respectable 3% decline in net profit. Capex slowed sharply in1H17 and while this is a prudent move, future growth might also slow. Withthe shares trading on 33x FY17 EPS, this slower future growth does not seemto be factored in; retaining Sell.

Quarterly data show a deteriorating trend

2Q17 revenue declined 5% while gross profit fell 17%, a deterioration vs. thetrends seen in 1Q17. The company cut its 2Q sales and marketing expense by23% and management expense by 18% in order to deliver a flat profit but thisclearly had an impact on customer acquisition with net adds reducing to 100kin the quarter (vs. an average of 700k in the past 2 years). With Dr. Peng’sbroadband ARPU at RMB42/m, still significantly higher than China Mobile atRMB35/m, and given limited bundling offerings to differentiate its offerings,we think Dr. Peng’s business model continues to be challenged. Capex diddecline to RMB1.2bn in 1H17 from an average of RMB1.9bn in the previousfour halves, but the pace of its network rollout also slowed, adding only 2mhouseholds in coverage in the half.

Earnings changes

We have reduced our earnings forecasts in line with the lower-than-expected1H17 results. We have removed the equity raising, which increased the EPS.

Valuation and risks

We value Dr. Peng based on the mid-point of our peer-based valuation andDCF. Risks relate to market share, tax rate, regulation, and margins.

  • 行情
  • 资金流
  • 核心数据
  • 分时
  • 日K
  • 周K
  • 月K
鹏博士基本面数据
  • 总股本 14.32亿股
  • 流通股 14.32亿股
  • 每股收益 0.06元
  • 每股未分配利润 1.96元
  • 每股净资产 4.89元
  • 净资产收益率 1.26%
  • 净利润 9104.06万
  • 净利润增长率 -47.18%
鹏博士投资评级
一月内整体评级
三月内整体评级
统计时段 买入 增持 中性 减持 卖出 合计
一个月内000000
三个月内000000
半年内100001
一年内12300217
鹏博士盈利预测
指标 2017A 2018E 2019E 2020E
每股收益(元) 0.54 0.71 0.86 0.00
净利润(亿元) 7.69 10.16 12.26 0.00
名称 涨跌幅 研报数 机构投资评级(近六个月)
买入 增持 中性 减持 卖出
光环新网 4.42% 19 10 9 0 0 0
二六三 1.87% 0 0 0 0 0 0
国脉科技 1.80% 0 0 0 0 0 0
中国联通 1.21% 15 9 6 0 0 0
鹏博士 0.82% 1 1 0 0 0 0
机构一致看多个股
名称 研报 看多家数 最高
目标价
最低
目标价
现价
上汽集团详细7635.8631.8832.40
银轮股份详细5712.998.469.26
完美世界详细5640.6028.6028.89
安科生物详细5334.4518.6219.08
乐普医疗详细5142.8821.2937.08
智飞生物详细5050.1516.5649.00
贵州茅台详细46901.50662.47741.13
宋城演艺详细4624.3618.7626.61
华鲁恒升详细4524.1816.2018.48
隆基股份详细4453.7521.6815.08
华兰生物详细4435.6726.6234.77
中航沈飞详细4438.5027.9038.21
中国国旅详细4379.3847.7373.46
锦江股份详细4340.2531.7534.32
光线传媒详细4313.729.829.61

数据来源:东方财富Choice数据